Lv1
30 积分 2026-09-01 加入
Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors
11小时前
待确认
Discovery of Novel Non-nucleoside DOT1LR231Q Inhibitors with Improved Pharmacokinetic Properties and Anti-lung Cancer Efficacy
11小时前
已完结
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
1个月前
已完结
Pleural mesothelioma
1个月前
已完结
Crystal structures of PAK2 reveal new insights into its autoinhibitory mechanism
1个月前
已完结
Immunotherapy approaches for malignant pleural mesothelioma
1个月前
已完结
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
1个月前
已完结
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
1个月前
已完结
皖公网安备34019202002308
